Solid Biosciences Inc.
SLDB
$5.93
$0.274.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.53% | 0.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.10% | 0.39% | |||
| Operating Income | -4.10% | -0.39% | |||
| Income Before Tax | -0.50% | 7.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.50% | 7.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.50% | 7.78% | |||
| EBIT | -4.10% | -0.39% | |||
| EBITDA | -4.19% | -0.60% | |||
| EPS Basic | 29.17% | 40.64% | |||
| Normalized Basic EPS | 29.18% | 40.63% | |||
| EPS Diluted | 29.17% | 40.64% | |||
| Normalized Diluted EPS | 29.18% | 40.63% | |||
| Average Basic Shares Outstanding | 41.90% | 55.34% | |||
| Average Diluted Shares Outstanding | 41.90% | 55.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||